It looks like your browser is outdated. For the best experience, please consider updating to the latest version or switching to another browser (Firefox, Chrome, Safari).

This page is not supported in mobiles. Please view it in the desktop version.

BioPharma Solutions BioPharma Solutions
Sterile Contract Manufacturing

History

Print

We understand parenterals.

Baxter’s heritage is built on over 80 years of innovation in healthcare, including a long list of “firsts.” As with the first manufacturer prepared intravenous (IV) solutions, Baxter continues to make history with life-saving and sustaining products.

Two years after its founding in 1931, the company opened its first manufacturing facility in a renovated automobile showroom in Glenview, Illinois, USA. There, six employees turned out the complete line of five intravenous solutions in glass containers. Baxter’s history of innovation continued with several other notable “firsts”:

  • The first closed system IV containers
  • The first premixed drug solutions
  • The first company to form alliances with pharmaceutical companies to package their drugs in IV containers

These firsts demonstrate a vision, a passion, and a continuous and relentless focus on advancing patient care. Our long-standing history of innovation puts unique expertise at your fingertips.

Baxter / BioPharma Solutions’ History and Timelines
Year Milestone
1930 Company founded as the Don Baxter Intravenous Products Corporation by Drs. Ralph Falk and Don Baxter as the first manufacturer of commercially prepared intravenous (IV) Solutions.
1933 Opened first manufacturing facility in a renovated automobile showroom in Glenview, Illinois, USA, where six employees produced complete line of five IV solutions in glass containers.
1954 Expanded internationally with the opening of an office in Belgium.
1969 Opened research facility in Round Lake, Illinois, USA
1970 Introduced first plastic container for intravenous (IV) solutions.
1974 Introduced first premixed drug solution
1979 Introduced first aseptic prepared frozen premix system.
1981 Baxter begins to partner with pharmaceutical companies with FLAGYL IV RTU being the first product approved by the FDA.
1983 ANCEF (cefazolin injection) was the first frozen, aseptically- filled product approved by a pharmaceutical partner.
1999 Published Baxter’s first sustainability report covering the triple bottom line of social, economic, and environmental issues.
2000 Acquired Biodome S.A., which added vial reconstitution systems, BIO-SET Luer and BIO-SET Infusion to Baxter’s portfolio of products.
2001 Completed acquisition of Bloomington manufacturing facility.
2003 Announced plans for a 120,000 square foot expansion of the company’s Bloomington, Indiana facility in the United States.
2006 Expanded lyophilization capacity in Halle/Wesfalen, Germany. Bloomington, Indiana, USA facility is awarded Facility of the Year Award by the International Society of Pharmaceutical Engineering (ISPE).
2008 Awarded North American Contract Manufacturing Customer Service Leadership of the Year Award by Frost and Sullivan
2009 Awarded Most Effective Scale-Up/Technical Transfer for Managing a Fast Track Project in cGMP Environment at the European Outsourcing Awards.
2010 Awarded the Best Contract Manufacturing Organization at the Vaccine Industry Excellence Awards.
2011 Completed 4th capacity expansion of Halle/Westfalen, Germany facility to support cytotoxic contract manufacturing services.
Awarded the Best Contract Manufacturing Organization at the Vaccine Industry Excellence Awards.
2012 Awarded the Best Contract Manufacturing Organization at the Vaccine Industry Excellence Awards.
2013 CMO Leadership Awards (Life Science Leader Magazine), Recognized for Quality, Reliability, Productivity, Regulatory & Innovation
2014 Baxter BioPharma Solutions and SAFC collaborate on complete ADC offering
2015 Completed 5th capacity expansion of Halle/Westfalen, Germany facility to support cytotoxic contract manufacturing services.
Awarded the Best Contract Manufacturing Organization at the Vaccine Industry Excellence Awards.
2016 Awarded ISPE's 2016 Facility of the Year (FOYA)Category Award for Operational Excellence (Halle, Germany facility expansion)
CMO Leadership Awards (Life Science Leader Magazine), Recognized for Capabilities, Compatibility, Expertise, Quality, Reliability.

FLAGYL and RTU are registered trademarks of G.D. Searle LLC
ANCEF is a registered trademark of GlaxoSmithKline.

Events Events
Events

Events

Talk to us at these events